Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2013-01-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1216526110PMID 23302696PMCID PMC3557100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magic-angle-spinning NMR of the drug resistant S31N M2 proton transporter from influenza A.

  2012cited by this paper
• Inhibitors of the M2 channel of influenza A virus

  2011cited by this paper
• Discovery of highly potent agents against influenza A virus.

  2011cited by this paper
• Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.

  2011cited by this paper
• Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel.

  2011cited by this paper
• Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial.

  2011cited by this paper
• Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

  2011cited by this paper
• Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

  2011cited by this paper
• Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy.

  2011cited by this paper
• Multiple Proton Confinement in the M2 Channel from the Influenza A Virus.

  2010cited by this paper
• Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus

  2010cited by this paper
• Structure of the Amantadine Binding Site of Influenza M2 Proton Channels In Lipid Bilayers

  2010cited by this paper
• Proton and cation transport activity of the M2 proton channel from influenza A virus

  2010cited by this paper
• Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer

  2010cited by this paper
• Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel.

  2010cited by this paper
• Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006–2008

  2009cited by this paper
• Large-Scale Sequence Analysis of M Gene of Influenza A Viruses from Different Species: Mechanisms for Emergence and Spread of Amantadine Resistance

  2009cited by this paper
• High prevalence of amantadine resistance among circulating European porcine influenza A viruses.

  2009cited by this paper
• Mechanism of drug inhibition and drug resistance of influenza A M2 channel

  2009cited by this paper
• Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

  2009cited by this paper
• Structure and mechanism of the M2 proton channel of influenza A virus

  2008cited by this paper
• Structural basis for the function and inhibition of an influenza virus proton channel

  2008cited by this paper
• High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2)

  2008cited by this paper
• The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus.

  2008cited by this paper
• Structural basis for the function and inhibition of an influenza virus proton channel

  2008cited by this paper
• The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain.

  2007cited by this paper
• The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.

  2007cited by this paper
• Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

  2007cited by this paper
• Amantadine Resistance among Porcine H1N1, H1N2, and H3N2 Influenza A Viruses Isolated in Germany between 1981 and 2001

  2006cited by this paper
• Anti‐influenza virus agents: Synthesis and mode of action

  2006cited by this paper
• Antiviral agents active against influenza A viruses

  2006cited by this paper
• Protein NMR Spectroscopy: principles and practice, 2nd ed.

  2006cited by this paper
• Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance Mutations

  2005cited by this paper
• The Xplor-NIH NMR molecular structure determination package.

  2003influential reference
• Emergence of amantadine-resistant influenza A viruses: epidemiological study

  2003cited by this paper
• The hydration of amides in helices; a comprehensive picture from molecular dynamics, IR, and NMR

  2003cited by this paper
• High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.

  2003cited by this paper
• Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients

  1999cited by this paper
• Characterizing the use of perdeuteration in NMR studies of large proteins: 13C, 15N and 1H assignments of human carbonic anhydrase II.

  1996cited by this paper
• Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block

  1993cited by this paper
• Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.

  1992cited by this paper
• The molecular basis of the specific anti‐influenza action of amantadine.

  1985cited by this paper

• Boron Clusters Versus Adamantane: A Comparative Study of Inorganic and Organic Scaffolds Against Resistant Influenza A

  2026cites this paper
• Prediction of the small molecule selectivity index against influenza virus strain A/H1N1 using machine learning methods

  2025cites this paper
• Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs – Challenges in designing antiviral agents

  2025influential citation
• Avian Influenza Virus: Comparative Evolution as the Key for Predicting Host Tropism Expansion

  2025cites this paper
• Discovery of adamantane-based α-hydroxycarboxylic acid derivatives as potent M2-S31N blockers of influenza A virus.

  2025cites this paper
• Anti-influenza drugs targeting trimeric RNA polymerase complex: From development to clinics

  2025cites this paper
• Exploring polycyclic scaffolds as adamantane replacements in M2 channel inhibitors of Influenza A virus

  2025cites this paper
• Evaluation of pandemic potential of the genotype 4 (G4) swine influenza virus using ex vivo and in vitro cultures of the human respiratory tract

  2025cites this paper
• Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist

  2025cites this paper
• Geographical distribution and evolutionary dynamics of H4Nx avian influenza viruses

  2025cites this paper
• Bat Influenza M2 Shows Functions Similar to Those of Classical Influenza A Viruses

  2025cites this paper
• Steady dimer formation by the S31N mutant of influenza A virus M2 protein in living cell membranes.

  2025cites this paper
• Amantadine derivative Amt-1 enhances antiviral defense against influenza A virus via Nrf2/HO-1 pathway.

  2025cites this paper
• Isoxazoles as efficient alkyne amination reagents in divergent heterocycle synthesis.

  2025cites this paper
• New adamantane-containing compounds targeting rimantadine-resistant influenza virus A/PR/8/34: molecular design, synthesis and SAR study

  2025cites this paper
• Rimantadine derivatives with antiviral activity against flaviviruses and rimantadine-resistant strain of influenza A virus

  2024cites this paper
• Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges.

  2024cites this paper
• Incompatible packaging signals and impaired protein functions hinder reassortment of bat H17N10 or H18N11 segment 7 with human H1N1 influenza A viruses

  2024cites this paper
• Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery

  2024cites this paper
• Drug resistance and possible therapeutic options against influenza A virus infection over past years

  2024cites this paper
• Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39

  2024cites this paper
• Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo

  2024cites this paper
• Two adamantan-1-amine-based scaffolds: Synthesis, crystallographic synthons, TD/DFT calculations, in-depth molecular docking/ADME/T simulations, and shedding light on antibacterial/fungal activities

  2023cites this paper
• Structural Basis for Interactions between Influenza A Virus M2 Proton Channel and Adamantane-Based Antiviral Drugs

  2023cites this paper
• A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid‐State NMR **

  2023cites this paper
• Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo

  2023cites this paper
• Camphecene and ginsamide: dynamics of potential interactions with the influenza virus M2 channel

  2023cites this paper
• A Novel Triple Reassortment H3N8 Avian Influenza Virus: Characteristics, Pathogenicity, and Transmissibility

  2023cites this paper
• The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins

  2023cites this paper
• Synthesis of an amantadine-based novel Schiff base and its transition metal complexes as potential ALP, α-amylase, and α-glucosidase inhibitors

  2023cites this paper
• [Influence of siRNA complexes on the reproduction of influenza A virus (Orthomyxoviridae: Alphainfluenzavirus) in vivo].

  2023cites this paper
• The Cytoplasmic Domain of the SARS-CoV-2 Envelope Protein Assembles into a β-Sheet Bundle in Lipid Bilayers

  2023cites this paper
• N-heterocyclic carbene-catalyzed direct enantioselective synthesis of dihydroisoxazolo[5,4-b]pyridin-6-ones

  2023cites this paper
• Genetic and Pathogenic Characterization of Avian Influenza Virus in Migratory Birds between 2015 and 2019 in Central China

  2022cites this paper
• Amantadine Variant – Aryl Conjugates that Inhibit Multiple M2 Mutant – Amantadine Resistant Influenza A Viruses

  2022cites this paper
• Knockdown of FLT4, Nup98, and Nup205 cellular genes effectively suppresses the reproduction of influenza virus strain A/WSN/1933 (H1N1) in vitro.

  2022cites this paper
• Folding Molecular Dynamics Simulations of the Transmembrane Peptides of Influenza A, B M2, and MERS-, SARS-CoV E Viral Proteins (preprint)

  2022cites this paper
• Tandem construction of biological relevant aliphatic 5-membered N-heterocycles.

  2022cites this paper
• Prevalence, Genetics and Evolutionary Properties of Eurasian Avian-like H1N1 Swine Influenza Viruses in Liaoning

  2022cites this paper
• In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein

  2022cites this paper
• Synthesis and Crystal Structure of Adamantylated 4,5,6,7-Tetrahalogeno-1H-benzimidazoles Novel Multi-Target Ligands (Potential CK2, M2 and SARS-CoV-2 Inhibitors); X-ray/DFT/QTAIM/Hirshfeld Surfaces/Molecular Docking Study

  2022cites this paper
• Knockdown of FLT4, Nup98, and Nup205 cellular genes as a suppressor for the viral activity of Influenza A/WSN/33 (H1N1) in A549 cell culture

  2022cites this paper
• Creation of a model for studying the antiviral effect of small interfering RNAs in vitro

  2022cites this paper
• POCl3-assisted synthesis of 2-amino-1,3,4-thiadiazole/1,3,4-oxadiazole derivatives as anti-influenza agents

  2022cites this paper
• Abuse of amantadine in poultry may be associated with higher fatality rate of H5N1 infections in humans

  2022cites this paper
• From Acid Activation Mechanisms of Proton Conduction to Design of Inhibitors of the M2 Proton Channel of Influenza A Virus

  2022cites this paper
• Cobalt complexes with biguanide derivatives – Synthesis, structure and antiviral activity

  2022cites this paper
• Essential Oils and Their Compounds as Potential Anti-Influenza Agents

  2022cites this paper
• Effect of antiviral siRNAs on the production of cytokines in vitro

  2022cites this paper
• A proof-of-concept study of the secondary structure of influenza A, B M2 and MERS- and SARS-CoV E transmembrane peptides using folding molecular dynamics simulations in a membrane mimetic solvent.

  2022cites this paper
• Ultrasensitive chemiluminescent neuraminidase probe for rapid screening and identification of small-molecules with antiviral activity against influenza A virus in mammalian cells

  2022cites this paper
• Can Spices Cure Flu?: A Multiple targets based Bioinformatics analysis

  2022cites this paper
• Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2

  2022cites this paper
• Genetic, biological and epidemiological study on a cluster of H9N2 avian influenza virus infections among chickens, a pet cat, and humans at a backyard farm in Guangxi, China

  2022cites this paper
• A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2

  2022cites this paper
• Amantadine Variant - Aryl Conjugates that Inhibit Multiple Amantadine Resistant M2 Mutant Influenza A Viruses

  2021cites this paper
• Influenza A M2 Channel Oligomerization is Sensitive to its Chemical Environment

  2021cites this paper
• Inside and Out of the Pore: Comparing Interactions and Molecular Dynamics of Influenza A M2 Viroporin Complexes in Standard Lipid Bilayers

  2021cites this paper
• Amantadine Variants Activity Against Multiple Influenza A Viruses

  2021cites this paper
• Reassortant Highly Pathogenic H5N6 Avian Influenza Virus Containing Low Pathogenic Viral Genes in a Local Live Poultry Market, Vietnam

  2021cites this paper
• Chemical Probes for Blocking of Influenza A M2 WT and S31N Channels

  2021cites this paper
• Identification and molecular characterization of H9N2 viruses carrying multiple mammalian adaptation markers in resident birds in central-western wetlands in India.

  2021cites this paper
• Highlighting membrane protein structure and function: A celebration of the Protein Data Bank

  2021cites this paper
• Understanding Molecular Mechanism of Biologics Drug Delivery and Stability from NMR Spectroscopy.

  2021cites this paper
• Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses

  2021cites this paper
• Spiers Memorial Lecture: Analysis and de novo design of membrane-interactive peptides.

  2021cites this paper
• Emergence of a Novel Reassortant H5N3 Avian Influenza Virus in Korean Mallard Ducks in 2018

  2021cites this paper
• Synthesis of Four Pentacyclic Triterpene–Sialylglycopeptide Conjugates and Their Affinity Assays with Hemagglutinin

  2021cites this paper
• Design and synthesis of pinane oxime derivatives as novel anti-influenza agents.

  2020cites this paper
• Chemical Probes for Blocking of Influenza A M2 WT and S31N Channels.

  2020cites this paper
• Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus

  2020influential citation
• Nitrene Transfer and Carbene Transfer in Gold Catalysis.

  2020cites this paper
• Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season

  2020cites this paper
• Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity

  2020cites this paper
• Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.

  2020cites this paper
• Amide-sialoside protein conjugates as neomucin bioshields prevent influenza virus infection.

  2020cites this paper
• [The potential of synthetic small interfering RNA-based antiviral drugs for influenza treatment].

  2020cites this paper
• Amantadine copper(II) chloride conjugate with possible implementation in influenza virus inhibition

  2020cites this paper
• (2-Hydroxy-4-methoxy)benzyl Aminoadamantane Conjugates as Probes to Investigate Specificity Determinants in Blocking Influenza M2 S31N and M2 WT Channels with Binding Kinetics and Simulations

  2020cites this paper
• Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.

  2020cites this paper
• Observation of the Imidazole-Imidazolium Hydrogen Bonds Responsible for Selective Proton Conductance in the Influenza A M2 Channel.

  2020cites this paper
• Mechanism and Origins of Product Selectivity of Au‐Catalyzed Coupling Benzisoxazoles with Ynamides: A Computational Study

  2020cites this paper
• Searching for effective antiviral small molecules against influenza A virus: A patent review

  2020cites this paper
• Rhodium(III)-catalysed decarboxylative C-H functionalization of isoxazoles with alkenes and sulfoxonium ylides.

  2020cites this paper
• Distribution and evolution of H1N1 influenza A viruses with adamantanes‐resistant mutations worldwide from 1918 to 2019

  2020cites this paper
• Put a cork in it: Plugging the M2 viral ion channel to sink influenza

  2020cites this paper
• Viroporins in the Influenza Virus

  2019cites this paper
• Approaches to primary tert-alkyl amines as building blocks

  2019cites this paper
• The L46P Mutant Confers a Novel Allosteric Mechanism of Resistance Toward the Influenza A Virus M2 S31N Proton Channel Blockers

  2019influential citation
• Current trends of hemagglutinin and M2 protein inhibition for the treatment of influenza using antivirals

  2019cites this paper
• Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors

  2019cites this paper
• Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus

  2019cites this paper
• X-ray crystal structure of the influenza A M2 proton channel S31N mutant in two conformational states: an open and shut case.

  2019cites this paper
• Adamantane Derivatives Containing Thiazole Moiety: Synthesis, Antiviral and Antibacterial Activity

  2019cites this paper
• Stalking Flu: Development and Characterization of a Broadly Neutralizing Monoclonal Antibody Targeting the Influenza Hemagglutinin Stem

  2019cites this paper
• Baloxavir marboxil: the new influenza drug on the market.

  2019cites this paper
• Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005-2016.

  2019cites this paper
• Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza

  2019influential citation
• Complete genome sequence of a novel reassortant H3N3 avian influenza virus

  2019cites this paper
• Rotation Barriers of 1‐Adamantyl‐Csp 3 Bonds Measured with Dynamic NMR

  2019cites this paper